The present invention relates to peptides proteins nucleic acids and cells for use in immunotherapeutic methods. In particular the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor associated T cell peptide epitopes alone or in combination with other tumor associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti tumor immune responses or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC) or peptides as such can also be targets of antibodies soluble T cell receptors and other binding molecules.
